ADAM12 induces estrogen-independence in breast cancer cells Roopali RoyMarsha A. Moses Preclinical study 09 March 2011 Pages: 731 - 741
Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas Rozina TufailMercy JordaZafar Nawaz Preclinical Study 12 March 2011 Pages: 743 - 750
Understanding of the immunological heterogeneity of canine mammary carcinomas to provide immunophenotypic features of circulating leukocytes as clinically relevant prognostic biomarkers Alessandra Estrela-LimaMárcio Sobreira Silva AraújoGeovanni Dantas Cassali Preclinical Study 30 March 2011 Pages: 751 - 763
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer Pascal JézéquelMario CamponeLoïc Campion Preclinical Study 31 March 2011 Pages: 765 - 775
Inhibitors of histone demethylation and histone deacetylation cooperate in regulating gene expression and inhibiting growth in human breast cancer cells Yi HuangShauna N. VasilatosNancy E. Davidson Preclinical Study 31 March 2011 Pages: 777 - 789
LDH-A silencing suppresses breast cancer tumorigenicity through induction of oxidative stress mediated mitochondrial pathway apoptosis Zhi-Yu WangTjing Yung LooJian-Ping Chen Preclinical Study 31 March 2011 Pages: 791 - 800
Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast Malgorzata BanysInes GruberTanja Fehm Preclinical Study 01 April 2011 Pages: 801 - 808
Deoxycytidine kinase is overexpressed in poor outcome breast cancer and determines responsiveness to nucleoside analogs Ernst-Jan GeutjesSun TianRené Bernards Preclinical Study 05 April 2011 Pages: 809 - 818
Can we avoid axillary dissection in the micrometastatic sentinel node in breast cancer? Viviana GalimbertiEdoardo BotteriUmberto Veronesi Preclinical study 06 April 2011 Pages: 819 - 825
Neoadjuvant chemotherapy in ER+ HER2− breast cancer: response prediction based on immunohistochemical and molecular characteristics E. H. LipsL. MulderS. Rodenhuis Preclinical study 07 April 2011 Pages: 827 - 836
The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer Ji-Yu LiZhou-Luo OuZhi-Ming Shao Preclinical study 09 April 2011 Pages: 837 - 848
Specific kinesin expression profiles associated with taxane resistance in basal-like breast cancer Min Han TanSarmishtha DeCharis Eng Preclinical study 09 April 2011 Pages: 849 - 858
Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer Anneke Q. van HoeselCornelis J. H. van de VeldeDave S. B. Hoon Preclinical study 11 April 2011 Pages: 859 - 869
A signature of immune function genes associated with recurrence-free survival in breast cancer patients Maria Libera AsciertoMaciej KmieciakMasoud H. Manjili Preclinical study 11 April 2011 Pages: 871 - 880
FOXA1 is an independent prognostic marker for ER-positive breast cancer Rutika J. MehtaRohit K. JainSunil Badve Preclinical Study 19 April 2011 Pages: 881 - 890
Daintain/AIF-1 promotes breast cancer cell migration by up-regulated TNF-α via activate p38 MAPK signaling pathway Tao LiZhiguo FengZhengwang Chen Preclinical Study 21 April 2011 Pages: 891 - 898
A phase I/II prospective, single arm trial of gefitinib, trastuzumab, and docetaxel in patients with stage IV HER-2 positive metastatic breast cancer G. SomloC. L. MartelS. E. Kane Clinical trial 01 November 2011 Pages: 899 - 906
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer Aditya BardiaErin T. ArieasVered Stearns Clinical trial 01 November 2011 Pages: 907 - 914
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer Michaela J. HigginsTatiana M. ProwellVered Stearns Clinical Trial 11 November 2011 Pages: 915 - 924
Endocrine therapy in obese patients with primary breast cancer: another piece of evidence in an unfinished puzzle R. WoltersL. SchwentnerA. Wöckel Clinical trial 13 November 2011 Pages: 925 - 931
A phase II study of 17-allylamino-17-demethoxygeldanamycin in metastatic or locally advanced, unresectable breast cancer Elaina M. GartnerPaula SilvermanPatricia M. LoRusso Clinical Trial 15 November 2011 Pages: 933 - 937
Individually tailored treatment with epirubicin and paclitaxel with or without capecitabine as first-line chemotherapy in metastatic breast cancer: a randomized multicenter trial T. HatschekL. CarlssonJ. Bergh Clinical trial 18 November 2011 Pages: 939 - 947
Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991 Robert C. BurtonRobin J. BellChristopher Stevenson Epidemiology 29 September 2011 Pages: 949 - 955
Trajectories of body image and sexuality during the first year following diagnosis of breast cancer and their relationship to 6 years psychosocial outcomes Wendy W. T. LamWylie W. Y. LiRichard Fielding Epidemiology 05 October 2011 Pages: 957 - 967
Breast tenderness after initiation of conjugated equine estrogens and mammographic density change Carolyn J. CrandallAaron K. AragakiRowan T. Chlebowski Epidemiology 07 October 2011 Pages: 969 - 979
Appendectomy and cancer risk in Jewish BRCA1 and BRCA2 mutation carriers Shiri BernholtzAriella Jakobson-SettonEitan Friedman Epidemiology 09 October 2011 Pages: 981 - 985
Incidence and risk factors for axillary web syndrome after breast cancer surgery Anke BergmannValéria Vasconcellos MendesErica Alves Nogueira Fabro Epidemiology 11 October 2011 Pages: 987 - 992
Alcohol intake and mammographic density in postmenopausal Norwegian women Samera Azeem QureshiElisabeth CoutoGiske Ursin Epidemiology 13 October 2011 Pages: 993 - 1002
Normal breast tissue of obese women is enriched for macrophage markers and macrophage-associated gene expression Xuezheng SunPatricia Casbas-HernandezMelissa A. Troester Epidemiology 15 October 2011 Pages: 1003 - 1012
Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008 Lotte Holm LandSusanne Oksbjerg DaltonMarianne Ewertz Epidemiology 16 October 2011 Pages: 1013 - 1020
Variation in the risk of radiation-related contralateral breast cancer by histology and estrogen receptor expression in SEER Gila NetaWilliam F. AndersonAmy Berrington Epidemiology 21 October 2011 Pages: 1021 - 1027
Clinician awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery setting Emily K. TamLing ShenMarilyn L. Kwan Epidemiology 29 October 2011 Pages: 1029 - 1038
Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer Hong ShiMelanie BevierAsta Försti Epidemiology 26 October 2011 Pages: 1039 - 1047
High level of miR-21, miR-10b, and miR-31 expression in bilateral vs. unilateral breast carcinomas Aglaya G. IyevlevaEkatherina Sh. KuliginaEvgeny N. Imyanitov Brief Report 05 November 2011 Pages: 1049 - 1059
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer L. C. CollinsJ. D. MarottiA. H. Partridge Brief Report 13 November 2011 Pages: 1061 - 1066
Prediction of menopausal status from estrogen-related gene expression in benign breast tissue Oukseub LeeIrene B. HelenowskiSeema A. Khan Brief Report 19 November 2011 Pages: 1067 - 1076
Parity and mortality from causes other than breast cancer in breast cancer patients Mai KadiPetra A. WarkElio Riboli Letter to the Editor 28 December 2011 Pages: 1077 - 1081
Erratum to: Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis Theodoros N. SergentanisKonstantinos P. Economopoulos Erratum 30 July 2010 Pages: 1083 - 1083
Erratum to: Enhanced serine production by bone metastatic breast cancer cells stimulates osteoclastogenesis Sirkku PollariSanna-Maria KäkönenOlli Kallioniemi Erratum 13 July 2011 Pages: 1085 - 1086
